EpiBone is pioneering a transformative approach to skeletal repair by utilizing a three-step process that leverages the patient's own cells to create personalized bone grafts. The process begins with imaging and stem cell extraction, where a CT scan is used to determine the precise 3D shape and size of the required bone, while adult stem cells are harvested from the patient's abdominal fat. Following this, a custom scaffold is designed to match the anatomical needs, and a bioreactor is constructed to nurture the stem cells as they differentiate into bone cells. This innovative bioreactor technology, developed over two decades, is crucial for mimicking the conditions necessary for bone growth, ensuring optimal nourishment, temperature, and pressure for cell survival and maturation.

The end result of EpiBone's process is a living bone graft that is not only tailored to the individual patient but also capable of continued growth and remodeling post-implantation. By using the patient's own cells, the risk of immune rejection is significantly reduced, leading to better integration and healing outcomes. This approach represents a significant leap in tissue engineering, moving away from traditional methods that often involve painful surgeries and long recovery times, towards a future where the body’s own regenerative capabilities are harnessed for more effective and personalized medical solutions.

United States

EpiBone is a revolutionary bone reconstruction company that allows patients to "grow their own bone". EpiBone's pioneering technology utilizes a scan of the patient's bone defect and the patient's own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

EpiBone

Company Details